MDX-210: Filed IND to expand Phase II trial

Medarex Inc. (MEDX), Princeton, N.J. Product: MDX-210 humanized bispecific antibody targeted to HER-2 protein on cancer cells and to white cell receptors Indication: Cancers expressing HER-2 Status: F...